CXCR4 marks homeostatically activated dendritic cells in the steady state and in cancer.

Authors

Mariana Pereira da Costa, Cécile Piot, Margarida Bonifacio, Victor Bosteels, Adi Biram, Estelle Wu, Lies van Baarle, Michael D Buck, Caetano Reis E Sousa

Published in

Cell reports. Volume 45. Issue 8. Pages 117769. Jul 30, 2026. Epub Jul 30, 2026.

Abstract

Conventional dendritic cells (cDCs) can be activated by pathogen signals and inflammation to drive T cell immunity to infection, but they can also undergo "homeostatic activation" at steady state. However, homeostatically activated cDCs closely resemble those activated by microbial or viral stimuli, hindering their study. Here, we identify the chemokine receptor CXCR4 as a specific marker of homeostatically activated cDCs across mouse tissues. CXCR4 is induced in cDCs in the steady state but not following stimulation with Toll-like receptor agonists or type I interferons. In tumors, CXCR4 expression or a gene signature derived from mouse spleen CXCR4^hi cDCs marks the so-called "mregDCs" that have acquired tumor-derived material. Notably, the gene signature derived from mouse spleen CXCR4^hi cDCs further identifies mregDCs in human cancers. Thus, CXCR4 distinguishes homeostatic from inflammatory cDC activation programs, providing a means to identify and study this cDC state in both physiological and pathological contexts.

PMID:
42536482
Bibliographic data and abstract were imported from PubMed on 01 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.